Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Genedx Holdings Corp (WGS)

Genedx Holdings Corp (WGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 545,050
  • Shares Outstanding, K 26,054
  • Annual Sales, $ 202,570 K
  • Annual Income, $ -175,770 K
  • 60-Month Beta 2.16
  • Price/Sales 2.20
  • Price/Cash Flow N/A
  • Price/Book 1.25
Trade WGS with:

Options Overview Details

View History
  • Implied Volatility 126.34% ( -11.50%)
  • Historical Volatility 162.07%
  • IV Percentile 26%
  • IV Rank 14.70%
  • IV High 701.71% on 10/31/23
  • IV Low 27.16% on 11/15/23
  • Put/Call Vol Ratio 0.77
  • Today's Volume 922
  • Volume Avg (30-Day) 274
  • Put/Call OI Ratio 1.68
  • Today's Open Interest 2,467
  • Open Int (30-Day) 1,117

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.55
  • Number of Estimates 1
  • High Estimate -0.55
  • Low Estimate -0.55
  • Prior Year -1.65
  • Growth Rate Est. (year over year) +66.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.63 +125.88%
on 04/18/24
21.49 -9.26%
on 05/01/24
+10.17 (+109.00%)
since 04/02/24
3-Month
3.63 +437.19%
on 02/05/24
21.49 -9.26%
on 05/01/24
+15.66 (+407.81%)
since 02/02/24
52-Week
1.16 +1,581.03%
on 11/16/23
21.49 -9.26%
on 05/01/24
+11.38 (+140.21%)
since 05/02/23

Most Recent Stories

More News
PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care

/PRNewswire/ -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing solutions and GeneDx (Nasdaq: WGS), a leader in...

PACB : 1.7600 (+4.14%)
WGS : 19.50 (-6.79%)
Why GeneDx Holdings Stock Lagged the Market Today

A financial-engineering move about to be made by the company is an indication of some deep and challenging problems.

WGS : 19.50 (-6.79%)
NDAQ : 60.07 (+0.32%)
Elevance (ELV) to Divest Life & Disability Business to StanCorp

With the sale of the life and disability business, Elevance Health (ELV) is focusing on growing its more profitable operations.

ICLR : 301.07 (-0.18%)
MDXH : 2.97 (+11.24%)
ELV : 525.61 (+0.15%)
WGS : 19.50 (-6.79%)
Why Shares of GeneDx Dropped Wednesday

The potential of a reverse split concerned investors.

WGS : 19.50 (-6.79%)
Similar Genomics Systems (OMIC) Reports Q4 Loss, Tops Revenue Estimates

Similar Genomics Systems (OMIC) delivered earnings and revenue surprises of 21.62% and 27.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

OMIC : 0.4000 (-1.74%)
WGS : 19.50 (-6.79%)
Agilon Health (AGL) Reports Q4 Loss, Tops Revenue Estimates

Agilon (AGL) delivered earnings and revenue surprises of -75% and 3.52%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

AGL : 4.83 (-2.62%)
WGS : 19.50 (-6.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn.

See More

Key Turning Points

3rd Resistance Point 23.07
2nd Resistance Point 21.98
1st Resistance Point 20.74
Last Price 19.50
1st Support Level 18.41
2nd Support Level 17.32
3rd Support Level 16.08

See More

52-Week High 21.49
Last Price 19.50
Fibonacci 61.8% 13.72
Fibonacci 50% 11.32
Fibonacci 38.2% 8.93
52-Week Low 1.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar